Pre-clinicians and medical researchers have anticipated the arrival of detection techniques based on hybrid photon counting (HPC). This revolutionary technology detects every single X-ray photon to deliver the highest sensitivity, best possible image quality, and lowest patient dose.
Additionally, the spectral capabilities of the HPC detector offers pre-clinical medical research new ways of exploring and imaging established modalities, plus create new ones.
Combining a direct-detection sensor with a pixel size of 75 μm, DECTRIS detectors distinguish the finest details and achieve ultra-high resolution. That is essential for applications such as micro-CT, mammography, or digital breast tomosynthesis (DBT), where the smallest relevant micro-calcifications occur in the 100 μm range. The system’s modulation transfer function (MTF) shows nearly ideal behavior — far beyond that of currently available mammography detectors.
In-vivo spectral (color) CT of a living mouse administered with two nanoparticle contrast agents, liposomal iodine shown in the blood vessels (red) and liposomal gadolinium (green) accumulated in the tumor. Acquired with a DECTRIS spectral detector prototype enabling 4-material decomposition. (Courtesy of C. Badea, Duke University).
HPC’s noise-free detection, utilized with a dedicated spectral weighting of lower and higher photons from different energy or spectrum bins, provide several advantages for HRCT. Read more
Sign up in DECTRIS E-Mail Newsletter for news, events, upgrades and special offers.
We assure you that your personal infomation will not be shared with others.